2013
DOI: 10.1007/s00424-013-1290-4
|View full text |Cite
|
Sign up to set email alerts
|

The calcineurin inhibitor cyclosporine A improves lipopolysaccharide-induced vascular dysfunction but does not rescue from cardiovascular collapse in endotoxemic mice

Abstract: The calcineurin inhibitor cyclosporine A (CsA) improves survival in endotoxemic mice. It was hypothesized that CsA counteracts the bradycardia and hypotension characteristic of endotoxemia. Vascular reactivity was determined in lipopolysaccharide (LPS; 50 μg/mL)-treated mouse aortic rings suspended in a myograph. Arterial blood pressure and heart rate were measured continuously with indwelling catheters in conscious mice treated with CsA and a bolus injection of LPS (2 mg/kg). The α1-adrenoceptor agonist pheny… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
5
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 28 publications
1
5
0
Order By: Relevance
“…In the other study, the same cardiovascular and inflammatory responses elicited by endotoxemia were largely eliminated after consequent administration of CSA . This latter study finding is consistent with the capacity of CSA to increase vascular tone and blood pressure (BP) , decrease vascular expression of inducible nitric oxide synthase , and reduce nitric oxide production in macrophages exposed to inflammatory stimuli . Moreover, it emphasizes the importance of CSA as a potential therapeutic strategy for the management of endotoxic inflammatory and cardiovascular insults.…”
Section: Introductionsupporting
confidence: 78%
“…In the other study, the same cardiovascular and inflammatory responses elicited by endotoxemia were largely eliminated after consequent administration of CSA . This latter study finding is consistent with the capacity of CSA to increase vascular tone and blood pressure (BP) , decrease vascular expression of inducible nitric oxide synthase , and reduce nitric oxide production in macrophages exposed to inflammatory stimuli . Moreover, it emphasizes the importance of CSA as a potential therapeutic strategy for the management of endotoxic inflammatory and cardiovascular insults.…”
Section: Introductionsupporting
confidence: 78%
“…In both models of sepsis, CO and stroke volume were found to decline initially, indicating impaired cardiac function as of 6 h, consistent with previous reports ( 27 , 29 , 51 ) ( Table 2 ). Neither the presence of a telemetry probe during echocardiographic recording, nor the induction of anesthesia and echocardiographic monitoring in telemetered mice was found to alter the hemodynamic profile relative to uninstrumented mice or previous reports ( 27 , 29 , 35 , 46 , 50 , 51 ), suggesting that both techniques can be used in concert without mutual interference.…”
Section: Resultsmentioning
confidence: 61%
“…This result indicates that the low dose of LPS challenge in the healthy rats resulted in a slight decrease in the blood pressure that was on behalf of a mild abdominal infection. The results from the work of Staehr et al (2013) showed that LPS bolus led to significant decreases in MAP (by approximately 30 mmHg) and heart rate (50% of baseline); moreover, the continuous infusion of cyclosporine A (CsA, 20 or 40 mg/kg/24 h), which is similar to Res, did not demonstrate an obvious effect on MAP and heart rate at 0–24 h after LPS administration. In the present work, the Res treatment had no obvious effect on the MAP levels of the rats subjected to LPS challenge, which was similar with the role of CsA in the previous study (Staehr et al, 2013).…”
Section: Discussionmentioning
confidence: 99%